{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:34:28Z","timestamp":1788838468998,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jconrel.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T01:59:43Z","timestamp":1610503183000},"page":"45-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs"],"prefix":"10.1016","volume":"331","author":[{"given":"Estelle J.A.","family":"Suys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.S.","family":"Brundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W.","family":"Pouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.H.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00487-5","article-title":"Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract","volume":"25","author":"Horter","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2021.01.007_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2133\/dmpk.22.225","article-title":"Solubility and dissolution profile assessment in drug discovery","volume":"22","author":"Sugano","year":"2007","journal-title":"Drug Metab Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-409X(96)00494-2","article-title":"Lipid-based vehicles for the oral delivery of poorly water soluble drugs","volume":"25","author":"Humberstone","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2021.01.007_bb0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.jconrel.2021.01.007_bb0025","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1007\/s11095-013-1126-0","article-title":"Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion\/absorption pathway","volume":"30","author":"Williams","year":"2013","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.01.007_bb0030","first-page":"79","article-title":"Exploring gastrointestinal variables affecting drug and formulation behavior: methodologies","volume":"519","author":"Hens","year":"2016","journal-title":"challenges and opportunities. Int J Pharm."},{"key":"10.1016\/j.jconrel.2021.01.007_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Sjogren","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.01.007_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpharm.2011.05.009","article-title":"The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate","volume":"414","author":"Do","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2021.01.007_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.10.016","article-title":"Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate","volume":"86","author":"Griffin","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.jconrel.2021.01.007_bb0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1208\/s12248-014-9589-4","article-title":"In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate","volume":"16","author":"Thomas","year":"2014","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2012.11.026","article-title":"Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues","volume":"453","author":"Bevernage","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2021.01.007_bb0060","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpb.2012.07.009","article-title":"Drug precipitation-permeation interplay: Supersaturation in an absorptive environment","volume":"82","author":"Bevernage","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.jconrel.2021.01.007_bb0065","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s11095-015-1843-7","article-title":"Porter CJH. A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations","volume":"33","author":"Crum","year":"2016","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11095-017-2331-z","article-title":"Closed-loop Doluisio (Colon, small intestine) and single-pass intestinal perfusion (Colon, jejunum) in rat\u2014biophysical model and predictions based on Caco-2","volume":"35","author":"Lozoya-Agullo","year":"2017","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.01.007_bb0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2016.09.061","article-title":"Segmental-dependent permeability throughout the small intestine following oral drug administration: single-pass vs. Doluisio approach to in-situ rat perfusion","volume":"515","author":"Lozoya-Agullo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.01.007_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2015.01.001","article-title":"Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies","volume":"90","author":"Stappaerts","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.jconrel.2021.01.007_bb0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s13346-017-0383-6","article-title":"Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems","volume":"8","author":"Sadhukha","year":"2018","journal-title":"Drug Deliv Transl Res."},{"issue":"4","key":"10.1016\/j.jconrel.2021.01.007_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11095-017-2327-8","article-title":"Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations","volume":"35","author":"Keemink","year":"2018","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2021.01.007_bb0095","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s11095-011-0623-2","article-title":"Application of dissolution\/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development","volume":"29","author":"Kataoka","year":"2012","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2021.01.007_bb0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1021\/acs.molpharmaceut.6b00792","article-title":"Transient supersaturation supports drug absorption from lipid-based formulations for short periods of time, but ongoing solubilization is required for longer absorption periods","volume":"14","author":"Crum","year":"2017","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2021.01.007_bb0105","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/acs.molpharmaceut.8b00206","article-title":"Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a type IV lipid-based formulation","volume":"15","author":"Suys","year":"2018","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2021.01.007_bb0110","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.01.007_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5173(98)00054-4","article-title":"Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine","volume":"167","author":"Khoo","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2021.01.007_bb0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s11095-006-9194-z","article-title":"Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs","volume":"24","author":"Cuine","year":"2007","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/jpet.102.045328","article-title":"Porter CJH. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum","volume":"305","author":"Johnson","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2021.01.007_bb0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijpharm.2014.11.035","article-title":"In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities","volume":"478","author":"Stappaerts","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2021.01.007_bb0135","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1021\/mp300164u","article-title":"Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems","volume":"9","author":"Anby","year":"2012","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2021.01.007_bb0140","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1021\/mp500197b","article-title":"An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations","volume":"11","author":"Anby","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.01.007_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2014.07.037","article-title":"Stealth\u2019 lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug","volume":"192","author":"Feeney","year":"2014","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(00)00349-5","article-title":"Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion","volume":"199","author":"Lyons","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of rat and mouse gastrointestinal pH fluid and lymphoid tissue, and implications for in-vivo experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.jconrel.2021.01.007_bb0160","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/mp300469m","article-title":"Dynamic analysis of fluid distribution in the gastrointestinal tract in rats: positron emission tomography imaging after Oral Administration of Nonabsorbable Marker, [F-18]Deoxyfluoropoly(ethylene glycol)","volume":"10","author":"Takashima","year":"2013","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2021.01.007_bb0165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"issue":"5","key":"10.1016\/j.jconrel.2021.01.007_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory-animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.jconrel.2021.01.007_bb0175","doi-asserted-by":"crossref","first-page":"510","DOI":"10.18433\/J3F602","article-title":"Regional differences in the components of luminal water from rat gastrointestinal tract and comparison with other species","volume":"15","author":"Tanaka","year":"2012","journal-title":"J Pharm Pharm Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2021.01.007_bb0180","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)38051-2","article-title":"Studies on fat digestion, absorption, and transport in the suckling rat. III. Composition of bile and evidence for enterohepatic circulation of bile salts","volume":"23","author":"Staggers","year":"1982","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.jconrel.2021.01.007_bb0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156652407780059168","article-title":"Enzymes in the conversion of cholesterol into bile acids","volume":"7","author":"Norlin","year":"2007","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0190","first-page":"33","article-title":"The absorption of water and salt from the small intestine of the rat","volume":"42","author":"Mc","year":"1957","journal-title":"Q J Exp Physiol Cogn Med Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2021.01.007_bb0195","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI106734","article-title":"The mechanism of decreased intestinal sodium and water absorption after acute volume expansion in the rat","volume":"50","author":"Humphreys","year":"1971","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2021.01.007_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1194\/jlr.D800041-JLR200","article-title":"Improved analysis of bile acids in tissues and intestinal contents of rats using LC\/ESI-MS","volume":"50","author":"Hagio","year":"2009","journal-title":"J. Lipid Res."},{"issue":"3\u20134","key":"10.1016\/j.jconrel.2021.01.007_bb0205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejps.2006.06.004","article-title":"Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract","volume":"29","author":"Masaoka","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.01.007_bb0210","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejpb.2019.07.007","article-title":"Developing a predictive in vitro dissolution model based on gastrointestinal fluid characterisation in rats","volume":"142","author":"Christfort","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.jconrel.2021.01.007_bb0215","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1021\/acs.molpharmaceut.7b00660","article-title":"Correlating in vitro solubilization and supersaturation profiles with in vivo exposure for lipid-based formulations of the CETP inhibitor CP-532,623","volume":"14","author":"McEvoy","year":"2017","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2021.01.007_bb0220","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1002\/jps.22226","article-title":"Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate","volume":"99","author":"Sassene","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2021.01.007_bb0225","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.molpharmaceut.6b00413","article-title":"In vivo precipitation of poorly soluble drugs from lipid-based drug delivery systems","volume":"13","author":"Sassene","year":"2016","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2021.01.007_bb0230","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11095-015-1829-5","article-title":"The precipitation behavior of poorly water-soluble drugs with an emphasis on the digestion of lipid-based formulations","volume":"33","author":"Khan","year":"2016","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.jconrel.2021.01.007_bb0235","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1021\/acs.molpharmaceut.8b00699","article-title":"Impact of drug physicochemical properties on lipolysis-triggered drug supersaturation and precipitation from lipid-based formulations","volume":"15","author":"Alskar","year":"2018","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592100016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592100016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:51:50Z","timestamp":1759161110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592100016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":47,"alternative-id":["S016836592100016X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.007","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}